BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 6263471)

  • 21. [Cis-dichlorodiammineplatinum, adriamycin and cyclophosphamide versus cis-dichlorodiammineplatinum, adriamycin, cyclophosphamide and CCNU in non-small cell carcinoma of the lung].
    Sanz Ortiz J; Saiz García F
    Med Clin (Barc); 1982 Nov 16-30; 79(9):403-6. PubMed ID: 6296560
    [No Abstract]   [Full Text] [Related]  

  • 22. [Prevention of bronchopulmonary inflammation in patients with lung cancer receiving cytostatic therapy].
    Viazitskiĭ PO; Iakovlev VN; Alekseev VG; Dmitriev IuK; Duganov VK
    Klin Med (Mosk); 1988 Jun; 66(6):64-7. PubMed ID: 2460668
    [No Abstract]   [Full Text] [Related]  

  • 23. Chemotherapy for metastatic non-small cell bronchogenic carcinoma: EST 2575, generation III, HAM versus CAMP.
    Ruckdeschel JC; Mehta CR; Salazar OM; Creech RH; Sponzo RW
    Cancer Treat Rep; 1981; 65(11-12):959-63. PubMed ID: 6794909
    [TBL] [Abstract][Full Text] [Related]  

  • 24. "CAMP" combination chemotherapy for unresectable non-oat cell bronchogenic carcinoma.
    Lad T; Sarma PR; Diekamp U; Tichler T; Chawla M; Krauss S; Zawila P; Nelson R
    Cancer Clin Trials; 1979; 2(4):321-6. PubMed ID: 394868
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immediate versus postponed combination chemotherapy (CAMP) for unresectable non-small cell lung cancer: a randomized trial.
    Lad TE; Nelson RB; Diekamp U; Kukla LJ; Sarma PR; Larson CS; Currie ET; Chawla MS; Tichler T; Zawila P; McGuire WP
    Cancer Treat Rep; 1981; 65(11-12):973-8. PubMed ID: 7028259
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Polychemotherapy and radiotherapy for small cell cancer of the lung].
    Linchenko IF; Danil'ian VM
    Vopr Onkol; 1983; 29(9):106-14. PubMed ID: 6314659
    [No Abstract]   [Full Text] [Related]  

  • 27. [Adriamycin in the combined chemotherapy of small-cell lung cancer].
    Perevodchikova NI; Bychkov MB; Ausekar BV
    Antibiotiki; 1983 Aug; 28(8):628-32. PubMed ID: 6314882
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chemotherapy of small cell carcinoma of the lung: comparison of a cyclic alternative combination with simultaneous combinations of four and seven agents.
    Alberto P; Berchtold W; Sonntag R; Barrelet L; Jungi F; Martz G; Obrecht P
    Eur J Cancer Clin Oncol; 1981 Sep; 17(9):1027-33. PubMed ID: 6276185
    [No Abstract]   [Full Text] [Related]  

  • 29. Methotrexate in the chemotherapy of lung cancer.
    Smyth JF; Ford HT
    Cancer Treat Rep; 1981; 65 Suppl 1():161-3. PubMed ID: 6275986
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cyclophosphamide and VP-16-213 with or without cisplatin in squamous cell and small cell lung cancers.
    Eagan RT; Frytak S; Nichols WC; Ingle JN; Creagan ET; Kvols LK
    Cancer Treat Rep; 1981; 65(5-6):453-8. PubMed ID: 6263477
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Polychemotherapy using methotrexate, adriamycin, cyclophosphamide and CCNU (MACC) in patients with advanced adenocarcinoma and large cell carcinoma of the lung].
    Karnicka-Młodkowska H; Jassem J; Mierzewski P; Słupek A; Mierzwa W; Decker E; Prokop A; Krawczyk K; Kowal E; Firlik M
    Pneumonol Pol; 1986 Dec; 54(12):546-51. PubMed ID: 3035511
    [No Abstract]   [Full Text] [Related]  

  • 32. MACC (methotrexate, adriamycin, cyclophosphamide and CCNU) in advanced lung cancer.
    Chahinian AP; Mandel EM; Holland JF; Jaffrey IS; Teirstein AS
    Cancer; 1979 May; 43(5):1590-7. PubMed ID: 221093
    [No Abstract]   [Full Text] [Related]  

  • 33. Oat cell carcinoma of the lung: combination chemotherapy with cyclophosphamide, vincristine and procarbazine.
    Wittes RE; Hopfan S; Wittes JT; Golbey RB; Martini N
    Clin Bull; 1977; 7(1):21-4. PubMed ID: 212216
    [No Abstract]   [Full Text] [Related]  

  • 34. [Results of a cytostatic combination treatment of metastasized breast and small cell bronchial carcinoma during partial blockade of the cell cycle].
    Ammon J; Kreidler J; Goronzy J
    Strahlentherapie Sonderb; 1978; 75():126-33. PubMed ID: 233454
    [No Abstract]   [Full Text] [Related]  

  • 35. Preliminary results in the treatment of oat cell carcinoma of the lung by combined application of chemotherapy (CT) and whole-body hyperthermia.
    Engelhardt R; Neumann H; von der Tann M; Löhr GW
    Prog Clin Biol Res; 1982; 107():761-5. PubMed ID: 6300932
    [No Abstract]   [Full Text] [Related]  

  • 36. Chemotherapy versus chemoimmunotherapy with levamisole or Corynebacterium parvum in advanced lung cancer.
    Chahinian AP; Goldberg J; Holland JF; Reisman A; Jaffrey IS; Mandel EM
    Cancer Treat Rep; 1982 Jun; 66(6):1291-7. PubMed ID: 6282455
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term survivorship in small-cell anaplastic lung carcinoma.
    Ginsberg SJ; Comis RL; Gottlieb AJ; King GB; Goldberg J; Zamkoff K; Elbadawi A; Meyer JA
    Cancer Treat Rep; 1979 Aug; 63(8):1347-9. PubMed ID: 225029
    [No Abstract]   [Full Text] [Related]  

  • 38. Phase II study of procarbazine in small cell carcinoma of the lung.
    Pedersen AG; Sörenson S; Aabo K; Dombernowsky P; Hansen HH
    Cancer Treat Rep; 1982 Feb; 66(2):273-5. PubMed ID: 6275988
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Combined chemotherapy of bronchial carcinomas (author's transl)].
    Karrer K; Pridun N; Denck H
    Z Erkr Atmungsorgane; 1980; 155(1):21-40. PubMed ID: 6259843
    [No Abstract]   [Full Text] [Related]  

  • 40. The role of chemotherapy in the treatment of lung cancer.
    Selawry OS
    Semin Oncol; 1974 Sep; 1(3):259-72. PubMed ID: 4143488
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.